Tranexamic acid through intravenous, intramuscular and oral routes: an individual participant data meta-analysis of pharmacokinetic studies in healthy volunteers. (2019)
Attributed to:
The CRASH-3 Trial: Tranexamic acid for the treatment of significant traumatic brain injury.
funded by
GCRF
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/fcp.12474
PubMed Identifier: 31013357
Publication URI: http://europepmc.org/abstract/MED/31013357
Type: Journal Article/Review
Volume: 33
Parent Publication: Fundamental & clinical pharmacology
Issue: 6
ISSN: 0767-3981